Home › NDC Lookup › Ingredients › Tetrahydrozoline Hcl › 70677-1159-01
Foster and Thrive Original Formula Eye Drops Tetrahydrozoline HCl .05 g/100mL Solution/ Drops — NDC 70677-1159-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Foster and Thrive Original Formula Eye Drops Tetrahydrozoline HCl .05 g/100mL Solution/ Drops — NDC 70677-1159-1 (Billing 70677-1159-01)

by Strategic Sourcing Services LLC · 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER

This is a package of Foster and Thrive Original Formula Eye Drops Tetrahydrozoline HCl .05 g/100mL Solution/ Drops from Strategic Sourcing Services LLC, marketed since Jul 2023 and currently FDA-listed; retail pharmacies pay about $0.0969 per mL (NADAC). It is this product's only package size.

NDC 70677-1159-01
🏷️ FDA NDC (as labeled) 70677-1159-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Tetrahydrozoline Hcl (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0413-2026
Class II · Jun 13, 2023 — CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line. (K.C. Pharmaceuticals, Inc) · FDA recall D-0897-2023
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1159-1
Product NDC 70677-1159
11-digit billing NDC 70677115901
NCPDP billing unit ML — per mL (volume)
RxCUI 1052943
UNII 0YZT43HS7D
UPC 0010939958280
Application # M018
SPL Set ID 002da62b-aec6-8e2a-e063-6294a90a5efc
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-07-09
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance TETRAHYDROZOLINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 007771
GCN 32311
HICL code 015909
Ingredient (HICL) Tetrahydrozoline Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6D
Therapeutic class — specific (HIC3) Eye Vasoconstrictors (Otc Only)
AHFS code 52:32.00.00
AHFS class Vasoconstrictors
FDB label name FT EYE DROPS 0.05%
FDB brand name Eye Drops
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007771
  • GCN: 32311
  • HICL (First Databank): 015909
  • AHFS class code: 52:32.00.00
  • RxCUI (RxNorm): 1052943
Why two NDCs? The FDA registers this code as 70677-1159-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1159-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Sympathomimetics, plain class.

Drug family (ATC) Sympathomimetics, plain, Sympathomimetics used as decongestants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT EYE DROPS 0.05% Ingredient Tetrahydrozoline Hcl
📖 What it is MedlinePlus · NLM

Ophthalmic tetrahydrozoline is used to relieve minor eye irritation and redness caused by colds, pollen, and swimming.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves the redness you see, but it doesn't treat the underlying cause of the irritation. Think of it as a short-term fix to take the red out. If something is genuinely botheri...
  • What exactly does this eye drop do — does it actually fix what's irritating my eye?
  • No — you should remove your contact lenses before putting in the drops. The solution can be absorbed by soft contacts, which can affect the lens and potentially irritate your eye....
  • Can I wear my contact lenses while using these drops?
📖 Read our full Tetrahydrozoline Ophthalmic guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.097 $1.45 / 15 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Jan 2026 Feb 2026 $0.097 $0.097
Flat over the last 3 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70677-1159-01 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 BOX / 15 mL in 1 BOTTLE, DROPPER 2023-07-09 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy Eye Drops Original Formula .05 g/100mL 24385-0075-05 AmerisourceBergen 1 bottle $0.097 — Discontinued —
Foster and Thrive Original Formula Eye Drops .05 g/100mLthis 70677-1159-01 Strategic 1 bottle $0.097 — Availability likely —
Quality Choice Eye Drops Redness Relief .05 g/100mL 83324-0340-15 Chain 1 bottle $0.097 — Availability likely —
Sunmark Eye Drops Original Formula .05 g/100mL 49348-0037-29 Strategic 1 bottle $0.115 — FDA listed +19%
Walgreens Eye Drops Original 15mL and twin pack .05 g/100mL 00363-4550-01 Walgreens 1 bottle — — FDA listed —
Kroger Eye Drops Original .05 g/100mL 30142-0574-01 The 1 bottle — — FDA listed —
TopCare Health Original Eye Drops .05 g/100mL 36800-0858-01 Topco 1 bottle — — FDA listed —
HEB Original Eye Drops .05 g/100mL 37808-0577-01 HEB 1 bottle — — FDA listed —
Meijer Redness Relief .05 g/100mL 41250-0814-01 Meijer 1 bottle — — FDA listed —
GoodSense Eye Drops Original Formula .05 g/100mL 50804-0141-01 Geiss, 1 bottle — — FDA listed —
CAREALL Eyedrops Original .5 mg/mL 51824-0039-05 New 15 ml — — Discontinued —
Discount Drug Mart Eye Drops Original .05 g/100mL 53943-0073-01 Discount 1 bottle — — FDA listed —
Family Wellness Original Redness Relief Eye Drops .05 g/100mL 55319-0907-01 Family 1 bottle — — FDA listed —
Medics Choice Eye Drops Original Redness Reliever .5 mg/mL 55651-0005-01 KC 1 bottle — — FDA listed —
Original Redness Reliever .05 g/100mL 55651-0063-01 KC 1 bottle — — FDA listed —
DG Original Eye Drops .05 g/100mL 55910-0363-01 Dolgencorp 1 bottle — — FDA listed —
CVP Sterile Eye Drops .05 g/100mL 57243-0068-01 Salado 1 bottle — — FDA listed —
Preferred Plus Pharmacy Redness Relief Eye Drops .05 g/100mL 61715-0212-01 Kinray 1 bottle — — FDA listed —
Best Choice Eye Drops Original .05 g/100mL 63941-0139-01 Valu 1 bottle — — FDA listed —
Redness Reliever, Circle K .5 mg/mL 66715-5429-04 Lil' 1 bottle — — FDA listed —
Lil Drug Store Eye Drops Redness Reliever .5 mg/mL 66715-6832-04 Lil 1 bottle — — FDA listed —
CIRCLE K sterile eye drops .05 g/100mL 66715-8882-01 Lil' 1 bottle — — FDA listed —
Lil Drug Store Sterile Eye Drops Redness Reliever .05 g/100mL 66715-8883-01 Lil' 1 bottle — — FDA listed —
Winco Original Formula Eye Drops .05 g/100mL 67091-0310-15 WinCo 1 bottle — — FDA listed —
Equate Eye Drops .5 mg/mL 67172-0281-01 Prestige 1 bottle — — Discontinued —
Equate Eye Drops .5 mg/mL 67172-0282-01 Prestige 1 bottle — — Discontinued —
Harris Teeter Eye Drops Original .05 g/100mL 69256-0977-01 Harris 1 bottle — — FDA listed —
Visine Red Eye Comfort .5 mg/mL 69968-0355-01 Kenvue 1 bottle — — FDA listed —
Equate Original Eye Drops .05 g/100mL 79903-0158-05 Walmart, 1 bottle — — FDA listed —
Original Redness Reliever .05 g/100mL 79903-0363-01 Walmart 1 bottle — — FDA listed —
Equaline Sterile Eye Drops .05 g/100mL 83455-0210-01 United 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Jul 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII R57ZHV85D4
    Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 91MBZ8H3QO
    Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium chloride

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedJul 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 11 words ▾

Use relieves redness of the eye due to minor eye irritations

⏱️ Dosage and Administration 15 words ▾

Directions instill 1 to 2 drops in the affected eye(s) up to 4 times daily

⚠️ Warnings 127 words ▾

Warnings For external use only Ask a doctor before use if you have narrow angle glaucoma When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lenses before using Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Tetrahydrozoline HCl 0.05%

🧪 Inactive Ingredients 14 words ▾

Inactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium chloride

🎯 Purpose 3 words ▾

Purpose Redness reliever

📄 Ask a Doctor Before Use If 11 words ▾

Ask a doctor before use if you have narrow angle glaucoma

📄 When Using This Product 48 words ▾

When using this product pupils may become enlarged temporarily to avoid contamination, do not touch tip of container to any surface. Replace cap after using. if solution changes color or becomes cloudy, do not use overuse may produce increased redness of the eye remove contact lenses before using

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop use and ask a doctor if you experience eye pain changes in vision continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 7 words ▾

Other information store at 15°-30°C ( 59°-86°F)

📄 Questions or Comments 12 words ▾

Questions or comments? Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST

📄 Package Label / Principal Display Panel 16 words ▾

Foster & Thrive Original Formula Eye Drops 15mL Foster & Thrive Original Formula Eye Drops 15mL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Foster and Thrive Original Formula Eye Drops (this brand).

Top reported reactions

Fatigue3
Alanine Aminotransferase Increased2
Aspartate Aminotransferase Increased2
Asthenia2
Blood Alkaline Phosphatase Increased2
Dysgeusia2
Fall2

Age at onset

Elderly1

Reporter sex

13 reports
Male · 54%
Female · 46%

Serious outcomes

Hospitalization7
Death2
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70677-1158-01 · Strategic 70677-1160-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.